NCT01103440View on ClinicalTrials.gov

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Stable Angina
Interventions
DRUG

Intravenous Glycoprotein inhibitor + ASA, Clopidogrel

IV Glycoprotein IIb/IIIa inhibitor bolus intra procedurally

DRUG

Antiplatelet Therapy (ASA, Clopidogrel)

Standard antiplatelet PCI treatment

Trial Locations (1)

10029

Mount Sinai Medical Center, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT01103440 - Aspirin Resistance and Percutaneous Coronary Intervention (PCI) | Biotech Hunter | Biotech Hunter